The following questions should be considered before, during and after contemplating the cases:
1
How can scientists effectively engage the government on matters of biosecurity and vice versa?
2
Is the recently inaugurated NSABB a sufficient institutional means of self-review for biotechnology research?
3
What changes to everyday research practice or policy could both maintain the freedom of research inquiry and improve national security?
4
As research advancements expose potentially dangerous new technologies or techniques, how should these emerging vulnerabilities or threats be addressed?
